What do systematic reviews say?

Intervention not reported

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 270 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in adverse events (N) (low certainty).

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  RR 1.81 [0.83, 3.96]
  2 studies · 170 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Intervention not reported

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 51 participants
  Very low

Intervention not reported

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 106 participants
  Very low

Intervention not reported

The review found no eligible studies for this question.

• Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found